Working To Reach Everyone, Everywhere
Our commitment to equitable access
Pfizer is firmly committed to equitable and affordable access to the Pfizer-BioNTech COVID-19 vaccine to help bring an end to the pandemic for everyone, everywhere.
We are extremely proud of the fact that, to-date, 161 countries around the world have already received doses of the Pfizer-BioNTech vaccine, and we are expanding that reach every day, working with governments and our global health partners to ensure doses reach more and more people.
Every day, we are working tirelessly with governments and our global health partners to ensure doses reach the arms of even more people.
Pfizer and BioNTech will produce 3 billion doses in 2021 and 4 billion doses in 2022
We have pledged:
2 billion doses
to low- and middle-income countries through 2022 - at least one billion each year - in order to reach lower income countries and the 2/3rds of the world’s poor living in middle income countries.
As of November 21, 2021, Pfizer has delivered:
More Than 2.1 billion doses to 161 countries
741 million + doses
to low and middle income countries as part of our pledge, and we are hard at work, along with our partners, planning for substantial doses deliveries that will take place through the rest of 2021.
In order to continue our efforts toward equitable access, we rely on multiple pathways to enable the fastest and most efficient ways to get vaccines to countries of all economic levels around the world and to leverage the resources and expertise of partners who can offer support for logistics, financing and advocacy where they may be needed. This includes:
Direct Supply Agreements
Pfizer has 64 direct supply agreements with country governments to reach more than 140 countries worldwide. More than half of these agreements are with low- and middle-income countries.
Pfizer and BioNTech have an agreement to supply 40 million doses to the COVAX facility. To date, 57 countries have received these doses.
Pfizer is actively working with governments around the world on donation of doses to countries in need. This includes programs like the U.S. Government’s agreement to purchase 1 billion doses at a not for profit price to donate to low- and lower-middle-income countries and Africa through 2022. More than 120 million doses have been delivered to 52 countries to date.
In addition to doses already allocated to support refugee populations in Jordan and Lebanon, Pfizer continues to explore additional paths and is providing support to help strengthen health systems for vulnerable populations across the world.